Clinical Trial Update: BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BG9924 in combination with methotrexate for active rheumatoid arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BG9924
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED